Use of amiodarone to prevent atrial fibrillation after cardiac surgery.
Brantman
Laura
L
University of California, San Francisco, USA.
Howie
Jill
J
D000638:Amiodarone / Q000494:pharmacology / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects* / Q000451:nursing / Q000706:statistics & numerical data; D002986:Clinical Trials as Topic; D003422:Critical Care / Q000379:methods; D004334:Drug Administration Schedule; D004347:Drug Interactions; D016903:Drug Monitoring / Q000379:methods / Q000451:nursing; D004562:Electrocardiography; D006301:Health Services Needs and Demand; D006801:Humans; D007430:Intraoperative Care / Q000379:methods / Q000451:nursing; D015999:Multivariate Analysis; D024802:Nurse's Role; D011182:Postoperative Care / Q000379:methods / Q000451:nursing; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D012307:Risk Factors; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D000889:Anti-Arrhythmia Agents; D000638:Amiodarone